Replies to post #2072 on Galectin Therapeutics Inc (GALT)

[thefamilyman]

That schedule looks very tight for the GALTW shares. Let's hope that there will at least be an interim look at the CX trial in 2016. Or perhaps the CX trial could end early for efficacy like the ICPT trial did last year...

The FX trial is not recruiting yet & not planning on reporting out until end of 2016 as per the last 10-Q.
The Psoriasis trial has not started recruiting yet either. its a 12 week trial, than follow for a year before reporting, so that will be end of 2016 at best.
10-Q said enough $$ until Sept 2016, so not enough cash to complete any trial.
Sucks not to have the chance to see possible good results before kicking in the ATM again.
- DirectionalDriller

[jmh0602]

Where did you get your information because it contradicts the press release from June 29, 2015 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (GALT), a leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced the screening of the first five patients in its Phase 2 clinical trial with GR-MD-02 in nonalcoholic steatohepatitis (NASH) with cirrhosis.

Also, my favorite part: In addition, non-invasive tests as secondary endpoints will be conducted at the beginning, middle and end of the study."

Also, screening for FX was supposed to start in August so it very well may have already